glp-1 no bmi requirement Big policy shift in obesity medicine. Starting July 1, 2026, Medicare will launch a temporary “GLP-1 Bridge” program allowing eligible patients to access drugs like Zepbound and Wegovy for about $50/month. For How Do You Qualify for
Description
Funny thing is a few articles from Attia I read were miscited or had the opposite reference of what was stated
"FDA Approves New Medication for Chronic Weight Management." FDA.gov CVS Caremark
State drug utilization data
10.1053/j.ackd.2012.12.006 [DOI] [PubMed] [Google Scholar] 17
